📊 ECOR Key Takeaways
Is electroCore, Inc. (ECOR) a Good Investment?
electroCore demonstrates strong revenue growth of 27.2% YoY with exceptional 87.3% gross margins, indicating market demand for its products. However, the company faces critical financial distress with negative stockholders' equity (-5.7M), negative operating cash flow (-3.0M), and accelerating net losses. At current burn rates with minimal liquidity runway, the company faces existential solvency risk without immediate profitability achievement or capital restructuring.
electroCore is delivering solid top-line growth and exceptionally high gross margins, which suggests the underlying product economics and commercial traction are improving. However, the business remains deeply unprofitable, is burning cash, and has negative stockholders' equity, indicating that balance sheet stress and funding risk still outweigh the revenue momentum. Until operating losses narrow materially and cash generation improves, the fundamentals remain weak.
Why Buy electroCore, Inc. Stock? ECOR Key Strengths
- Strong revenue growth of 27.2% YoY demonstrates market demand for electromedical technology
- Exceptional 87.3% gross margin indicates strong product economics and customer willingness to pay
- Cash position of 4.9M provides near-term operational liquidity
- Revenue grew 27.2% YoY, showing meaningful commercial expansion
- Gross margin of 86.8% indicates strong unit economics and pricing power
- Liquidity is still manageable near term with a 1.38x current ratio and $7.04M in cash
ECOR Stock Risks: electroCore, Inc. Investment Risks
- Negative stockholders' equity of -5.7M represents technical insolvency and existential bankruptcy risk
- Negative operating cash flow of -3.0M with accelerating losses demonstrates unsustainable unit economics
- Critically tight liquidity with current ratio of 1.02x and quick ratio of 0.86x limits refinancing options
- Long-term debt of 7.8M against cash of 4.9M creates near-term refinancing and covenant compliance risk
- Operating margin of -41.1% and net margin of -43.6% show the business model is not yet self-sustaining
- Negative stockholders' equity and liabilities above assets signal a stressed balance sheet
- Negative free cash flow of -$8.25M raises the risk of future capital needs or dilution
Key Metrics to Watch
- Operating cash flow trend and timeline to positive cash generation
- Monthly cash burn rate and runway to depletion at current operating levels
- Operating expense reduction progress toward achieving positive operating margins
- Debt covenant compliance status and refinancing negotiations timeline
- Operating cash burn and free cash flow trend
- Progress in operating margin and path to breakeven
electroCore, Inc. (ECOR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
electroCore, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
ECOR Profit Margin, ROE & Profitability Analysis
ECOR vs Healthcare Sector: How electroCore, Inc. Compares
How electroCore, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is electroCore, Inc. Stock Overvalued? ECOR Valuation Analysis 2026
Based on fundamental analysis, electroCore, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
electroCore, Inc. Balance Sheet: ECOR Debt, Cash & Liquidity
ECOR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: electroCore, Inc.'s revenue has grown significantly by 488% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.59 indicates the company is currently unprofitable.
ECOR Revenue Growth, EPS Growth & YoY Performance
ECOR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $6.7M | -$3.9M | $-0.47 |
| Q3 2025 | $6.6M | -$2.5M | $-0.31 |
| Q2 2025 | $6.1M | -$2.7M | $-0.38 |
| Q1 2025 | $5.4M | -$3.5M | $-0.47 |
| Q3 2024 | $4.5M | -$2.5M | $-0.31 |
| Q2 2024 | $3.6M | -$2.7M | $-0.38 |
| Q1 2024 | $2.8M | -$3.5M | $-0.53 |
| Q3 2023 | $2.0M | -$4.0M | $-0.68 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
electroCore, Inc. Dividends, Buybacks & Capital Allocation
ECOR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for electroCore, Inc. (CIK: 0001560258)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ECOR
What is the AI rating for ECOR?
electroCore, Inc. (ECOR) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 86% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ECOR's key strengths?
Claude: Strong revenue growth of 27.2% YoY demonstrates market demand for electromedical technology. Exceptional 87.3% gross margin indicates strong product economics and customer willingness to pay. ChatGPT: Revenue grew 27.2% YoY, showing meaningful commercial expansion. Gross margin of 86.8% indicates strong unit economics and pricing power.
What are the risks of investing in ECOR?
Claude: Negative stockholders' equity of -5.7M represents technical insolvency and existential bankruptcy risk. Negative operating cash flow of -3.0M with accelerating losses demonstrates unsustainable unit economics. ChatGPT: Operating margin of -41.1% and net margin of -43.6% show the business model is not yet self-sustaining. Negative stockholders' equity and liabilities above assets signal a stressed balance sheet.
What is ECOR's revenue and growth?
electroCore, Inc. reported revenue of $9.6M.
Does ECOR pay dividends?
electroCore, Inc. does not currently pay dividends.
Where can I find ECOR SEC filings?
Official SEC filings for electroCore, Inc. (CIK: 0001560258) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ECOR's EPS?
electroCore, Inc. has a diluted EPS of $-0.59.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ECOR a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, electroCore, Inc. has a SELL rating with 86% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ECOR stock overvalued or undervalued?
Valuation metrics for ECOR: ROE of N/A (sector avg: 15%), net margin of -55.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ECOR stock in 2026?
Our dual AI analysis gives electroCore, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ECOR's free cash flow?
electroCore, Inc.'s operating cash flow is $-3.0M, with capital expenditures of $2.0K. FCF margin is -31.4%.
How does ECOR compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -55.0% (avg: 12%), ROE N/A (avg: 15%), current ratio 1.02 (avg: 2).